Veterinary Medicines

Vomend 5 mg/ml solution for injection for dogs and cats

Authorised
  • Metoclopramide hydrochloride
Download as PDF

Product identification

Medicine name:
Vomend 5 mg/ml solution for injection for dogs and cats
Vomend 5 mg/ml oplossing voor injectie voor honden en katten
Active substance:
  • Metoclopramide hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Metoclopramide hydrochloride
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA03FA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • 50 ml vial of clear colourless glass type I. Bromobutyl rubber stoppers type I (the stoppers are secured with aluminium caps). 1 vial in a cardboard box.
  • 5 ml vial of clear colourless glass type I. Bromobutyl rubber stoppers type I (the stoppers are secured with aluminium caps). 1 vial in a cardboard box.
  • 10 ml vial of clear colourless glass type I. Bromobutyl rubber stoppers type I (the stoppers are secured with aluminium caps). 1 vial in a cardboard box.
  • 30 ml vial of clear colourless glass type I. Bromobutyl rubber stoppers type I (the stoppers are secured with aluminium caps). 1 vial in a cardboard box.
  • 25 ml vial of clear colourless glass type I. Bromobutyl rubber stoppers type I (the stoppers are secured with aluminium caps). 1 vial in a cardboard box.
  • 20 ml vial of clear colourless glass type I. Bromobutyl rubber stoppers type I (the stoppers are secured with aluminium caps). 1 vial in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 106887
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0145/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Italy
  • Luxembourg
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/01/2022
Download

Summary of Product Characteristics

English (PDF)
Published on: 16/06/2022
Download

106887 par.pdf

English (PDF)
Published on: 16/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."